XMTR vs ELVN
Comparison between Xometry Inc - Class A (XMTR, Company) and Enliven Therapeutics Inc (ELVN, Company).
XMTR is from the Industrials sector, while ELVN is from the Healthcare sector.
5-Year PerformanceELVN has outperformed XMTR, delivering a return of +21.1% compared to +3.8%
XMTR vs ELVN - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
XMTR vs ELVN - Historical Returns
Returns include dividend reinvestment.
XMTR vs ELVN - Annual Returns (2020 - 2026)
Returns include dividend reinvestment.
| Year | XMTR | ELVN |
|---|---|---|
| 2026 | +44.25% | +282.37% |
| 2025 | +42.85% | -35.56% |
| 2024 | +23.08% | +51.01% |
| 2023 | +11.07% | -12.18% |
| 2022 | -40.23% | +69.71% |
| 2021 | -41.35% | -90.62% |
| 2020 | N/A | +47.00% |
XMTR vs ELVN Drawdown Comparison
The maximum drawdown for XMTR was -87.09%, occurring on Jul 1, 2024. Recovery took 1223 trading sessions.
The maximum drawdown for ELVN was -98.20%, occurring on Apr 12, 2022. This drawdown has not yet recovered.
The current XMTR drawdown is -13.66%. The current ELVN drawdown is -72.93%.
| Rank | XMTR | ELVN |
|---|---|---|
| #1 | -87.09% Jun 30, 2021 - May 14, 2026 | -98.20% Jun 11, 2020 - Apr 12, 2022 |
| #2 | -22.78% Jul 21, 2026 - Jul 29, 2026 | -16.67% May 5, 2020 - May 11, 2020 |
| #3 | -15.38% May 28, 2026 - Jun 30, 2026 | -12.88% May 11, 2020 - May 14, 2020 |
| #4 | -7.26% Jun 30, 2026 - Jul 13, 2026 | -9.82% Jun 4, 2020 - Jun 9, 2020 |
| #5 | -5.34% May 20, 2026 - May 26, 2026 | -8.61% Jun 9, 2020 - Jun 11, 2020 |
| #6 | -4.29% May 14, 2026 - May 20, 2026 | -6.02% Mar 19, 2020 - Apr 27, 2020 |
| #7 | -2.29% Jul 15, 2026 - Jul 20, 2026 | -5.50% May 15, 2020 - May 26, 2020 |
| #8 | N/A | -3.12% Mar 13, 2020 - Mar 19, 2020 |
| #9 | N/A | -2.15% Apr 28, 2020 - May 4, 2020 |
| #10 | N/A | -0.16% Jun 1, 2020 - Jun 3, 2020 |
Correlation
Correlation between XMTR and ELVN is 0.46 which considered as a weak positive correlation - the stocks show a slight tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks